Breaking News Instant updates and real-time market news.

2020-10-20 08:09:37 AXNX Axonics $47.64 / -0.5 (-1.04%) 08:09 10/20/20 10/20 08:09 10/20/20 08:09	Axonics launches ARTISTRY study for Axonics r-SNM System patients Axonics has launched a new post-market clinical registry study to collect and analyze real-world data of patients treated with the Axonics r-SNM System. The Axonics Sacral Neuromodulation System Registry, or ARTISTRY, a prospective, multicenter registry, anticipates enrolling up to 300 patients across 30 centers in the United States and Canada. Patients with symptoms of urinary urgency incontinence, urinary urgency frequency, non-obstructive urinary retention and fecal incontinence will be included in the study. ARTISTRY will collect real-world data on technical aspects of the procedure, effectiveness, safety, and patient experience with the Axonics System. Patients will be followed for one year, with clinical data documented and assessed at various time points over the course of the study.	04 Nov 20 Nov 08 May
AXNX Axonics $47.64 / -0.5 (-1.04%) 09/29/20 Morgan Stanley Survey indicates Street too conservative on Axonics, says Morgan Stanley 09/02/20 Baird Axonics initiated with an Outperform at Baird 08/04/20 Piper Sandler Proposed CMS rates positive for neuromodulation names, says PiperSandler 08/03/20 Piper Sandler Piper says Axonics positioned for continued share taking despite Medtronic nod

2020-10-20 08:09:37

AXNX

Axonics

$47.64 / -0.5 (-1.04%)

08:09

10/20/20

10/20

08:09

10/20/20

08:09

Axonics launches ARTISTRY study for Axonics r-SNM System patients

Axonics has launched a new post-market clinical registry study to collect and analyze real-world data of patients treated with the Axonics r-SNM System. The Axonics Sacral Neuromodulation System Registry, or ARTISTRY, a prospective, multicenter registry, anticipates enrolling up to 300 patients across 30 centers in the United States and Canada. Patients with symptoms of urinary urgency incontinence, urinary urgency frequency, non-obstructive urinary retention and fecal incontinence will be included in the study. ARTISTRY will collect real-world data on technical aspects of the procedure, effectiveness, safety, and patient experience with the Axonics System. Patients will be followed for one year, with clinical data documented and assessed at various time points over the course of the study.

04
Nov

20
Nov
08
May

AXNX Axonics

$47.64 / -0.5 (-1.04%)

09/29/20 Morgan Stanley: Survey indicates Street too conservative on Axonics, says Morgan Stanley

09/02/20 Baird: Axonics initiated with an Outperform at Baird

08/04/20 Piper Sandler: Proposed CMS rates positive for neuromodulation names, says PiperSandler

08/03/20 Piper Sandler: Piper says Axonics positioned for continued share taking despite Medtronic nod

TODAY'S FREE FLY STORIES

Recommendations	Honeywell named 'Catalyst Call: Buy Idea" at Deutsche Bank » 06:38 04/13/21 04/13 06:38 04/13/21 06:38 HON Honeywell $228.57 / +1.335 (+0.59%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HON Honeywell $228.57 / +1.335 (+0.59%) 04/08/21 Honeywell commits to carbon neutrality by 2035 04/01/21 Honeywell to provide technology for Pipistrel's unmanned cargo aircraft 03/15/21 Honeywell sees FY21 segment margin 20.7%-21.1% 03/15/21 Honeywell sees Q1 segment margin 20.4%-20.9% HON Honeywell $228.57 / +1.335 (+0.59%) 04/09/21 JPMorgan JPMorgan's Tusa raises target on top pick Honeywell to $250 from $200 04/08/21 Deutsche Bank Deutsche Bank upgrades Honeywell on 'rare buying opportunity' 04/08/21 Deutsche Bank Honeywell upgraded to Buy from Hold at Deutsche Bank 04/06/21 Barclays Honeywell price target raised to $230 from $225 at Barclays HON Honeywell $228.57 / +1.335 (+0.59%) 03/15/21 Honeywell sees FY21 EPS $7.60-$8.00, consensus $7.88 03/15/21 Honeywell sees Q1 EPS $1.68-$1.83, consensus $1.79 01/29/21 Honeywell sees Q1 EPS $1.68-$1.83, consensus $1.82 01/29/21 Honeywell sees FY21 adjusted EPS $7.60-$8.00, consensus $7.87 HON Honeywell $228.57 / +1.335 (+0.59%) 04/09/21 Honeywell, Carnival upgrades among today's top calls on Wall Street 01/29/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Pre-market Movers 12/22/20 Fly Intel: Wall Street's top stories for Tuesday 04/15/21 Aerospace & Defense 04/23/21 Honeywell - HON HON Honeywell $228.57 / +1.335 (+0.59%) 04/09/21 Early notable gainers among liquid option names on April 9th 03/29/21 Honeywell call volume above normal and directionally bullish 01/15/21 Honeywell call volume above normal and directionally bullish
Downgrade	Cadence Bancorp downgraded to Market Perform from Outperform at Raymond James » 06:37 04/13/21 04/13 06:37 04/13/21 06:37 CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 04/12/21 Cadence Bancorp rises 7.1% 04/12/21 BancorpSouth, Cadence Bancorp announce all-stock merger agreement 01/25/21 Cadence Bancorp reports book value per share $15.83 as of December 31 01/25/21 Cadence Bancorp raises dividend to 15c CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 06:10 Today RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 04/12/21 RBC Capital Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital 02/23/21 Stephens Stephens raises Regions price target to $23, sees possible deal for Cadence 08/18/20 Keefe Bruyette Cadence Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 01/25/21 Cadence Bancorp reports Q4 adjusted EPS $1.57, consensus $1.48 10/21/20 Cadence Bancorp reports Q3 EPS 40c, consensus 19c CADE Cadence Bancorp $22.41 / +0.92 (+4.28%) 01/07/21 Fly Intel: After-Hours Movers 04/22/21 Cadence Bancorp - CADE 05/06/21 Cadence Bancorporation
Recommendations	Agco named 'Catalyst Call: Buy Idea' at Deutsche Bank » 06:37 04/13/21 04/13 06:37 04/13/21 06:37 AGCO Agco $148.83 / +1.33 (+0.90%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AGCO Agco $148.83 / +1.33 (+0.90%) 03/03/21 AGCO announces farmer-first strategy 02/19/21 Agco says TAFE letter to board makes 'a number of misleading statements' 10/13/20 Agco chief communication officer Ulrich Stockheim to depart company AGCO Agco $148.83 / +1.33 (+0.90%) 03/16/21 Citi Agco price target raised to $165 from $140 at Citi 03/05/21 Credit Suisse Agco price target raised to $142 from $131 at Credit Suisse 03/04/21 BMO Capital Agco price target raised to $200 from $155 at BMO Capital 03/04/21 Deutsche Bank Agco price target raised to $145 from $141 at Deutsche Bank AGCO Agco $148.83 / +1.33 (+0.90%) 02/04/21 Agco sees FY21 EPS $7.00-$7.25, consensus $6.28 02/04/21 Agco reports Q4 EPS $1.54, consensus $1.11 11/03/20 Agco raises FY20 adj. EPS view to approximately $5.00 from $3.50-$3.75 11/03/20 Agco reports Q3 EPS $2.09, consensus 98c 04/29/21 Agco - AGCO 04/22/21 AGCO Corporation
Hot Stocks	Cerevel Therapeutics announces $125M financing transaction for tavapadon » 06:36 04/13/21 04/13 06:36 04/13/21 06:36 CERE Cerevel Therapeutics $13.62 / +0.58 (+4.45%) Cerevel Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CERE Cerevel Therapeutics $13.62 / +0.58 (+4.45%) 01/28/21 Cerevel Therapeutics hosts R&D event to review darigabat 01/21/21 Cerevel Therapeutics appoints Deval Patrick, Deborah Baron to board 01/19/21 Inspire appoints Bryan Phillips as chief compliance officer, general counsel 01/19/21 Frequency Therapeutics appoints Quentin McCubbin as chief manufacturing officer CERE Cerevel Therapeutics $13.62 / +0.58 (+4.45%) 12/10/20 Goldman Sachs Cerevel Therapeutics initiated with a Buy at Goldman Sachs 11/23/20 Jefferies Cerevel Therapeutics initiated with a Buy at Jefferies 11/09/20 Fly Intel: Top five analyst initiations 11/09/20 Stifel Cerevel Therapeutics initiated with a Buy at Stifel CERE Cerevel Therapeutics $13.62 / +0.58 (+4.45%) 03/24/21 Cerevel Therapeutics reports Q4 EPS (27c), consensus (45c) CERE Cerevel Therapeutics $13.62 / +0.58 (+4.45%) 11/16/20 Fly Insider: Cerevel Therapeutics, Paylocity among weeks notable insider trades
Hot Stocks	Sierra Metals reports high-grade oxide polymetallic ore detection » 06:35 04/13/21 04/13 06:35 04/13/21 06:35 SMTS Sierra Metals $2.99 / -0.11 (-3.55%) Sierra Metals announces… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events SMTS Sierra Metals $2.99 / -0.11 (-3.55%) 03/16/21 Sierra Metals receives ITS permit to increase production in Yauricocha mine 01/08/21 Sierra Metals to explore potential strategic alternatives, including sale 12/10/20 Sierra Metals announces positive PEA results for Cusi Mine production increase 11/18/20 Sierra Metals reports mineral resource increase at Yauricocha Mine, Peru SMTS Sierra Metals $2.99 / -0.11 (-3.55%) 12/16/20 CIBC Sierra Metals price target raised to C$4.80 from C$3.50 at CIBC 11/10/20 CIBC Sierra Metals price target raised to C$3.50 from C$3.30 at CIBC 09/17/20 CIBC Sierra Metals price target raised to C$3.30 from C$2.60 at CIBC 09/11/20 CIBC CIBC starts Sierra Metals at Outperformer ahead of cash flow pickup 05/07/21 Sierra Metals - SMTS

Initiation	Coinbase initiated with a Buy at MoffettNathanson » 06:35 04/13/21 04/13 06:35 04/13/21 06:35 COIN Coinbase / + MoffettNathanson analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly COIN Coinbase / + 04/06/21 Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members 03/22/21 Coinbase ordered to pay $6.5M by CFTC for false, misleading reporting 12/17/20 Coinbase announces confidential submission of draft registration statement COIN Coinbase / + 04/07/21 JMP Securities Coinbase report shows 'substantial business momentum,' says JMP Securities 03/03/21 Fly Intel: Top five analyst initiations 03/03/21 DA Davidson Coinbase initiated with a Buy at DA Davidson COIN Coinbase / + 04/06/21 Coinbase gives Q2, FY21 expenses guidance 04/06/21 Coinbase reports Q1 estimated total revenue of $1.8B COIN Coinbase / + 04/06/21 Coinbase's independent directors will have direct ties to company, WSJ reports 03/21/21 Coinbase direct listing pushed back to April, Bloomberg reports 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/17/20 Coinbase filed confidentially for IPO, Bloomberg says COIN Coinbase / + 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 The Intersection: Crypto and Wall Street This Week 04/03/21 Opening Day: Softbank-backed Compass raises $450M in IPO 03/27/21 Opening Day: Vizio slides in NYSE debut after downsized IPO
Recommendations	3M named 'Catalyst Call: Sell Idea' at Deutsche Bank » 06:35 04/13/21 04/13 06:35 04/13/21 06:35 MMM 3M $197.73 / -0.28 (-0.14%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MMM 3M $197.73 / -0.28 (-0.14%) 03/17/21 3M has been able to secure some price increses, says CFO 03/17/21 3M: Cost inflation is 2x of what was contemplated in previous expectations 03/17/21 3M seeing higher materials, labor, logistics inflation, CFO says 03/10/21 3M awarded contract by Michigan Medicine for AI-powered revenue cycle tech MMM 3M $197.73 / -0.28 (-0.14%) 04/06/21 Barclays 3M price target raised to $180 from $163 at Barclays 03/23/21 Credit Suisse 3M price target raised to $202 from $197 at Credit Suisse 02/03/21 Fly Intel: Top five analyst upgrades 02/03/21 Argus 3M upgraded to Buy from Hold at Argus MMM 3M $197.73 / -0.28 (-0.14%) 01/26/21 3M sees FY21 EPS $9.20-$9.70, consensus $9.52 01/26/21 3M reports Q4 adjusted EPS $2.38, consensus $2.15 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MMM 3M $197.73 / -0.28 (-0.14%) 02/11/21 3M helping law enforcement stop sale of counterfeit N95 masks, CNBC reports 01/16/21 3M stock 'unloved, underpriced,' Barron's says MMM 3M $197.73 / -0.28 (-0.14%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Fly Intel: Pre-market Movers 12/14/20 Fly Intel: Pre-market Movers 05/11/21 3M Corp. MMM 3M $197.73 / -0.28 (-0.14%) 01/26/21 Unusually active option classes on open January 26th
Periodicals	Credit Suisse cuts employee bonuses following $4.7B Archegos loss, FT reports » 06:34 04/13/21 04/13 06:34 04/13/21 06:34 CS Credit Suisse $10.72 / +0.08 (+0.75%) Credit Suisse has cut… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CS Credit Suisse $10.72 / +0.08 (+0.75%) 04/11/21 Fly Intel: Top five weekend stock stories 04/06/21 Credit Suisse CEO of Investment Bank, Chief Risk Officer stepping down 04/06/21 Credit Suisse board launches investigations into hedge fund, supply chain 04/06/21 Credit Suisse expects Q1 CET1 ratio to be at least 12% CS Credit Suisse $10.72 / +0.08 (+0.75%) 04/12/21 UBS Credit Suisse price target lowered to CHF 10.20 from CHF 12.10 at UBS 04/09/21 Fly Intel: Top five analyst downgrades 04/09/21 Morgan Stanley Credit Suisse downgraded to Equal Weight from Overweight at Morgan Stanley 04/07/21 RBC Capital Credit Suisse price target lowered to CHF 11 from CHF 14.50 at RBC Capital CS Credit Suisse $10.72 / +0.08 (+0.75%) 04/06/21 Credit Suisse sees Q1 loss of CHF 900M, CHF $4.4B charge for hedge fund 02/18/21 Credit Suisse reports Q4 adjusted pretax income CHF861M vs. CHF955M last year CS Credit Suisse $10.72 / +0.08 (+0.75%) 04/12/21 Credit Suisse to scale bank on investment bank, WSJ reports 04/10/21 Credit Suisse crises slamming stock, investors should stay away, Barron's says 04/09/21 Credit Suisse asset management arm receiving interest, Reuters reports 04/08/21 Credit Suisse tightens hedge fund terms after Archegos, Bloomberg reports CS Credit Suisse $10.72 / +0.08 (+0.75%) 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/06/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Wall Street's top stories for Monday 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues CS Credit Suisse $10.72 / +0.08 (+0.75%) 04/08/21 Unusually active option classes on open April 8th 04/06/21 Unusually active option classes on open April 6th 04/05/21 Credit Suisse call volume above normal and directionally bullish 03/31/21 Unusually active option classes on open March 31st
Upgrade	Deutsche upgrades CommScope to Buy on 'significantly positive' spinoff » 06:33 04/13/21 04/13 06:33 04/13/21 06:33 COMM CommScope $17.29 / -0.21 (-1.20%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events COMM CommScope $17.29 / -0.21 (-1.20%) 04/08/21 CommScope announces plan to spin-off Home Networks business 01/18/21 CommScope files patent infringement suit against SOLiD in Germany 01/07/21 STACK INFRASTRUCTURE joins CommScope's MTDC Alliance Program 10/19/20 CommScope acquires complete vRAN patent portfolio from Phluido COMM CommScope $17.29 / -0.21 (-1.20%) 04:47 Today Deutsche Bank CommScope upgraded to Buy from Hold at Deutsche Bank 04/09/21 Wolfe Research CommScope price target raised to $23 from $20 at Wolfe Research 04/08/21 Rosenblatt CommScope upgraded to Buy at Rosenblatt on spinout and industry catalysts 04/08/21 Rosenblatt CommScope upgraded to Buy from Neutral at Rosenblatt COMM CommScope $17.29 / -0.21 (-1.20%) 02/17/21 CommScope reports Q4 adjusted EPS 59c, consensus 44c 02/16/21 Notable companies reporting before tomorrow's open 02/16/21 Notable companies reporting before tomorrow's open 11/05/20 CommScope reports Q3 adjusted EPS 51c, consensus 37c COMM CommScope $17.29 / -0.21 (-1.20%) 02/17/21 Fly Intel: Pre-market Movers 05/07/21 CommScope Holding Company, Inc.
Hot Stocks	Eli Lilly announces Diogo Rau as chief information, digital officer » 06:33 04/13/21 04/13 06:33 04/13/21 06:33 LLY Eli Lilly $181.76 / -2.71 (-1.47%) , AAPL Apple $131.27 / -1.72 (-1.29%) Eli Lilly (LLY) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY AAPL LLY Eli Lilly $181.76 / -2.71 (-1.47%) 04/12/21 Innovent/Eli Lilly's phase 3 study of TYVYT in sqNSCLC saw OS improvement 04/12/21 Eli Lilly modifies bamlanivimab purchase agreement with U.S. government 04/11/21 Eli Lilly presents new data on Retevmo in Advanced RET Fusion-Positive in GI 04/08/21 Eli Lilly, Incyte announce baricitinib study did not meet primary endpoint AAPL Apple $131.27 / -1.72 (-1.29%) 04/12/21 Apple Mac sales implied up 65% vs. 22% consensus, Gene Munster says 04/02/21 Apple adds over 30 titles to Arcade, bringing total to over 180 games 04/01/21 Apple building 'major' energy storage project in California 03/25/21 Hasbro's 'Magic: The Gathering Arena' now available on mobile devices LLY AAPL LLY Eli Lilly $181.76 / -2.71 (-1.47%) 04/12/21 Benchmark Benchmark sees full FDA approval of Regeneron's REGEN-COV coming 04/06/21 JPMorgan JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug 03/24/21 BMO Capital AbCellera price target lowered to $59 from $61 at BMO Capital 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho AAPL Apple $131.27 / -1.72 (-1.29%) 04/12/21 Canaccord Canaccord upgrades Tesla with over $1,000 target on 'Apple-esque' ecosystem 04/09/21 Citi Citi tells investors to focus on Apple's capital deployment, iPhone gains 04/08/21 Piper Sandler Teen iPhone ownership continues to increase, says Piper Sandler 04/06/21 Cowen Apple's News product a key growth pillar, says Cowen LLY AAPL LLY Eli Lilly $181.76 / -2.71 (-1.47%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open AAPL Apple $131.27 / -1.72 (-1.29%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year LLY AAPL LLY Eli Lilly $181.76 / -2.71 (-1.47%) 03/20/21 Still reasons to be hopeful about Lilly, Biogen Alzheimer's drugs, Barron's says 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says AAPL Apple $131.27 / -1.72 (-1.29%) 05:57 Today Apple's April 20 event prematurely revelead by Siri, MacRumors reports 04/12/21 Apple faces supply constraints with iPad Pros, Bloomberg reports 04/11/21 Apple agrees to testify before Senate on app store concerns, Reuters reports 04/09/21 Apple hires former WarnerMedia executive Jesse Henderson, Information says LLY AAPL LLY Eli Lilly $181.76 / -2.71 (-1.47%) 03/15/21 Fly Intel: Wall Street's top stories for Monday 03/15/21 Fly Intel: Wall Street's top stories at midday 03/15/21 Fly Intel: Pre-market Movers 03/10/21 Fly Intel: Wall Street's top stories for Wednesday AAPL Apple $131.27 / -1.72 (-1.29%) 04/12/21 Tesla, Chipotle upgrades among today's top calls on Wall Street 04/11/21 On the Fly: The Week in SPAC News 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021 04/27/21 Eli Lilly - LLY 04/28/21 Apple - AAPL 05/03/21 Eli Lilly & Co. 05/06/21 Eli Lilly LLY AAPL LLY Eli Lilly $181.76 / -2.71 (-1.47%) 03/11/21 Eli Lilly call volume above normal and directionally bullish 03/10/21 Eli Lilly call volume above normal and directionally bullish 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th AAPL Apple $131.27 / -1.72 (-1.29%) 04/12/21 Notable open interest changes for April 12th 04/09/21 Notable open interest changes for April 9th 04/09/21 Unusual call flow in option market yesterday 04/08/21 Apple options on track for 3M contract day as shares continue to rebound

Hot Stocks	Jowell Global announces strategic cooperation agreement with ZTO Express » 06:33 04/13/21 04/13 06:33 04/13/21 06:33 JWEL Jowell Global $8.15 / +0.4 (+5.16%) , ZTO ZTO Express $28.53 / +0.32 (+1.13%) Jowell Global (JWEL)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Options ZTO ZTO ZTO Express $28.53 / +0.32 (+1.13%) 03/31/21 ZTO Express increases share repurchase program to $1B 03/18/21 ZTO Express falls -7.1% 12/29/20 China's Standard for express delivery by unmanned aircraft effective Jan. 1 11/19/20 ZTO Express falls -9.1% JWEL ZTO JWEL Jowell Global $8.15 / +0.4 (+5.16%) ZTO ZTO Express $28.53 / +0.32 (+1.13%) 03/22/21 JPMorgan ZTO Express downgraded to Neutral from Overweight at JPMorgan 11/19/20 HSBC ZTO Express downgraded to Reduce from Hold at HSBC 11/19/20 Daiwa ZTO Express downgraded to Outperform from Buy at Daiwa 09/28/20 Bocom ZTO Express initiated with a Buy at Bocom 17 Mar JWEL JWEL Jowell Global $8.15 / +0.4 (+5.16%) 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO ZTO ZTO ZTO Express $28.53 / +0.32 (+1.13%) 03/17/21 ZTO Express options imply 8.4% move in share price post-earnings
Initiation	Benchmark starts Faraday Future partner Property Solutions Acquisition at Buy » 06:32 04/13/21 04/13 06:32 04/13/21 06:32 PSAC Property Solutions Acquisition $13.00 / -1.985 (-13.25%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options PSAC Property Solutions Acquisition $13.00 / -1.985 (-13.25%) 01/28/21 FF to become public through $3.4B Property Solutions Acquisition combination PSAC Property Solutions Acquisition $13.00 / -1.985 (-13.25%) 06:22 Today Benchmark Property Solutions Acquisition initiated with a Buy at Benchmark PSAC Property Solutions Acquisition $13.00 / -1.985 (-13.25%) 04/09/21 Largest borrow rate increases among liquid names 03/11/21 Largest borrow rate increases among liquid names 02/25/21 Largest borrow rate increases among liquid names 02/23/21 Largest borrow rate increases among liquid names
Hot Stocks	Avenue Therapeutics: FDA still reviewing NDA resubmission for IV tramadol » 06:32 04/13/21 04/13 06:32 04/13/21 06:32 ATXI Avenue Therapeutics $7.11 / +0.215 (+3.12%) Avenue Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ATXI Avenue Therapeutics $7.11 / +0.215 (+3.12%) 03/01/21 Avenue Therapeutics reports PDUFA date of April 12, 2021 set for IV Tramadol 02/17/21 Avenue Therapeutics resubmitted New Drug Application for IV tramadol 12/18/20 Avenue Therapeutics announces publication on teal-world data on NMU of tramadol 12/18/20 Avenue Therapeutics announces publication on tramadol non-medical use ATXI Avenue Therapeutics $7.11 / +0.215 (+3.12%) 03/01/21 H.C. Wainwright InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright 02/17/21 Dawson James Fortress Biotech price target raised to $21 from $16 at Dawson James 10/12/20 H.C. Wainwright Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright 10/12/20 H.C. Wainwright Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Downgrade	Aphria downgraded to Hold from Speculative Buy at Canaccord » 06:31 04/13/21 04/13 06:31 04/13/21 06:31 APHA Aphria / + Canaccord analyst Matt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options APHA Aphria / + 04/12/21 Uber CEO tells CNBC it may get into cannabis delivery 04/05/21 Aphria: ISS, Glass Lewis recommend shareholders vote 'FOR' Tilray merger 04/05/21 ISS, Glass Lewis recommend Tilray holders vote fo Aphria transaction 03/31/21 NY Governor Cuomo signs bill to legalize adult-use cannabis APHA Aphria / + 04/12/21 Alliance Global Partners Alliance Global trims Aphria price target to C$24, says long-term view intact 04/08/21 Alliance Global Partners Aphria price target raised to $26 from $20 at Alliance Global Partners 04/06/21 Stifel Aphria price target raised to C$22 from C$15.50 at Stifel 03/29/21 Stifel Stifel says New York adult use cannabis market represents $5B opportunity APHA Aphria / + 04/12/21 Aphria reports Q3 adjusted EPS (C$0.15) vs. (C$0.04) a year ago 01/14/21 Aphria reports Q2 adjusted EPS C$0.01 vs. (C$0.19) a year ago 10/15/20 Aphria reports Q1 EPS (C$0.02) vs. C$0.07 year ago APHA Aphria / + 03/24/21 Deal reached on bill legalizing marijuana in NY, Spectrum News NY1 says 03/17/21 Marijuana banking bill to be reintroduced, Marijuana Moment's Angell says 03/15/21 NY Governor Cuomo says state 'very close' to legalizing marijuana, RF says 03/11/21 Peoples-Stokes sees marijuana legalization deal soon, Buffalo News reports APHA Aphria / + 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 04/08/21 Rising High: Canopy Growth to acquire The Supreme Cannabis Company in $435M deal APHA Aphria / + 03/15/21 Aphria call volume above normal and directionally bullish 02/12/21 Aphria call volume above normal and directionally bullish 02/09/21 Aphria call volume above normal and directionally bullish 01/13/21 Aphria call volume above normal and directionally bullish
Downgrade	Norilsk Nickel downgraded to Hold from Buy at Societe Generale » 06:31 04/13/21 04/13 06:31 04/13/21 06:31 NILSY Norilsk Nickel $32.69 / +1.22 (+3.88%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NILSY Norilsk Nickel $32.69 / +1.22 (+3.88%) 04/09/21 UBS Norilsk Nickel downgraded to Neutral from Buy at UBS 03/12/21 Exane BNP Paribas Norilsk Nickel upgraded to Outperform from Neutral at Exane BNP Paribas 02/22/21 JPMorgan Norilsk Nickel downgraded to Neutral from Overweight at JPMorgan 11/04/20 Societe Generale Norilsk Nickel selloff looks overdone, says Societe Generale, upgrades to Buy

Periodicals	Black attended Apollo Global meeting days after resignation, FT reports » 06:29 04/13/21 04/13 06:29 04/13/21 06:29 APO Apollo Global $47.59 / +0.59 (+1.26%) Days after resigning from… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options APO Apollo Global $47.59 / +0.59 (+1.26%) 04/12/21 B. Riley Financial to replace Michaels in S&P 600 at open on 4/15 04/01/21 Athene announces 'significant pension risk transfer transaction' with JCPenney 03/22/21 Synnex, Tech Data to combine in $7.2B deal 03/22/21 Marc Rowan assumes CEO role of Apollo Global APO Apollo Global $47.59 / +0.59 (+1.26%) 04/12/21 Wells Fargo Apollo Global price target lowered to $57 from $62 at Wells Fargo 04/09/21 Deutsche Bank Apollo Global price target lowered to $49 from $52 at Deutsche Bank 04/05/21 JPMorgan Athene Holding downgraded to Neutral from Overweight at JPMorgan 03/23/21 Fly Intel: Top five analyst upgrades APO Apollo Global $47.59 / +0.59 (+1.26%) 03/22/21 Apollo CEO Leon Black stepping down to focus on family, health 02/03/21 Apollo Global reports Q4 fee related EPS 63c, consensus 50c 02/02/21 Notable companies reporting before tomorrow's open 02/02/21 Notable companies reporting before tomorrow's open APO Apollo Global $47.59 / +0.59 (+1.26%) 04/09/21 Apollo Global's Leon Black exit after sexual harassment claims, NY Post reports 04/01/21 Pioneer Natural near deal to acquire DoublePoint Energy for $6B, Reuters says 04/01/21 J.C. Penney to transfer $2.8B in pension obligations to Athene, Reuters says 03/25/21 Apollo exploring sale of textbook publisher McGraw-Hill, Bloomberg reports APO Apollo Global $47.59 / +0.59 (+1.26%) 03/25/21 Fly Intel: Wall Street's Top Stories for Thursday 03/22/21 Fly Intel: Wall Street's top stories for Monday 03/08/21 Fly Intel: Wall Street's top stories for Monday 03/08/21 Fly Intel: Wall Street's top stories at midday 05/04/21 Apollo Global - APO APO Apollo Global $47.59 / +0.59 (+1.26%) 03/17/21 $2.2M put block in Apollo Global Management suggests confidence into summer 10/22/20 Apollo Global put volume heavy and directionally bearish
Periodicals	Pinterest to add guidelines for influencers to ensure positivity, WSJ reports » 06:27 04/13/21 04/13 06:27 04/13/21 06:27 PINS Pinterest $83.97 / -1.6 (-1.87%) Pinterest is planning to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PINS Pinterest $83.97 / -1.6 (-1.87%) 04/07/21 Pinterest launches Creator Code content policy, Creator Fund 02/22/21 Pinterest director sells 350K shares of common stock 02/16/21 Third Point buys Upstart, exits Caesars in Q4 02/04/21 Pinterest jumps 8% to $84.15 after reporting Q4 results PINS Pinterest $83.97 / -1.6 (-1.87%) 04/05/21 Evercore ISI Pinterest initiated with an Outperform at Evercore ISI 03/30/21 Morgan Stanley Pinterest price target lowered to $89 from $95 at Morgan Stanley 03/22/21 BofA Pinterest downgraded to Neutral from Buy at BofA 03/22/21 BofA Pinterest downgraded to Neutral from Buy at BofA PINS Pinterest $83.97 / -1.6 (-1.87%) 02/04/21 Pinterest sees Q1 revenue growing in low-70% range, consensus $425.51M 02/04/21 Pinterest reports Q4 EPS 30c, consensus 32c 02/04/21 Notable companies reporting after market close 10/28/20 Pinterest sees Q4 revenue up 60 from last year PINS Pinterest $83.97 / -1.6 (-1.87%) 04/04/21 Pinterest said to be in talks to buy photo app VSCO, NY Times reports 02/11/21 Microsoft had talks with Pinterest for potential deal, Financial Times reported 02/11/21 Microsoft recently made offer to acquire Pinterest; talks not active, FT reports 12/15/20 Pinterest to pay $22.5M to settle gender discrimination suit, NY Times reports PINS Pinterest $83.97 / -1.6 (-1.87%) 04/07/21 #SocialStocks: AR glasses seen as future of tech 03/31/21 #SocialStocks: Social media CEOs give congressional testimony yet again 03/24/21 #SocialStocks: Facebook appeal deferred until European Court of Justice guidance 03/23/21 Game On: Microsoft in talks to buy Discord as Sony acquires EVO PINS Pinterest $83.97 / -1.6 (-1.87%) 02/11/21 Pinterest call volume above normal and directionally bullish 02/10/21 Pinterest call volume above normal and directionally bullish 02/05/21 Notable open interest changes for February 5th 02/04/21 Pinterest options imply 21.6% move in share price post-earnings
Downgrade	Lucira Health downgraded to Underperform from Buy at BofA » 06:25 04/13/21 04/13 06:25 04/13/21 06:25 LHDX Lucira Health $10.83 / +2.27 (+26.52%) BofA analyst Derik de… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly LHDX Lucira Health $10.83 / +2.27 (+26.52%) 04/12/21 FDA authorizes first single-use, PCR quality otc Lucira Covid test 04/09/21 Lucira Health COVID-19 test kit identifies viral variants 02/11/21 Lucira Health launches self-administered COVID-19 test in the U.S. 02/08/21 Lucira Health Inc trading resumes LHDX Lucira Health $10.83 / +2.27 (+26.52%) 06:04 Today BofA Lucira Health downgraded to Underperform from Buy at BofA 03/02/21 Lucira Health initiated with an Outperform at LifeSci Capital 03/02/21 William Blair Lucira Health initiated with an Outperform at William Blair 03/02/21 BofA Lucira Health initiated with a Neutral at BofA LHDX Lucira Health $10.83 / +2.27 (+26.52%) 06:22 Today Lucira Health sees Q1 revenue $4.0M-$4.5M, consensus $9.42M 05 Feb LHDX Lucira Health $10.83 / +2.27 (+26.52%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Periodicals	TSMC backs commitment to U.S. fab project, DigiTimes reports » 06:23 04/13/21 04/13 06:23 04/13/21 06:23 TSM TSMC $120.99 / -1.78 (-1.45%) TSMC chairman Mark Liu,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TSM TSMC $120.99 / -1.78 (-1.45%) 04/09/21 TSMC reports March revenue up 13.7% y/y to NT$129.13B 04/01/21 TSMC spending $100B over three years to 'keep up with demand' 03/10/21 TSMC reports February revenue NT$106.53B, up 14.1% y/y 02/09/21 TSMC reports January revenue NT$126.75B, up 22.2% y/y TSM TSMC $120.99 / -1.78 (-1.45%) 04/12/21 Fly Intel: Top five analyst initiations 04/12/21 Atlantic Equities TSMC initiated with a Neutral at Atlantic Equities 04/01/21 DA Davidson Onto Innovation price target raised to $80 from $75 at DA Davidson 03/29/21 Citi TSMC recent selloff brings 'enhanced buying opportunity,' says Citi TSM TSMC $120.99 / -1.78 (-1.45%) 01/14/21 TSMC sees Q1 revenue $12.7B-$13B, consensus $12.62B 01/14/21 TSMC reports Q4 EPS 97c, consensus 94c 10/15/20 TSMC sees Q4 revenue $12.4B-$12.7B, consensus $11.71B 10/15/20 TSMC reports Q3 EPS 90c, consensus 77c TSM TSMC $120.99 / -1.78 (-1.45%) 04/12/21 Chip shortage meeting not seen producing substantive outcomes, Bloomberg says 03/30/21 TSMC chairman says onshore chip supply chain 'unrealistic,' Nikkei reports 03/30/21 TSMC to move 4nm process to production ahead of schedule, DigiTimes reports 03/25/21 TSMC expected to remain major foundry partner of Intel, DigiTimes reports TSM TSMC $120.99 / -1.78 (-1.45%) 04/09/21 Fly Intel: Pre-market Movers 03/25/21 ViacomCBS downgrade, AMD upgrade among today's top calls on Wall Street 03/24/21 Street Fight: Analysts diverge on Intel following 'Unleashed' event 03/22/21 Before the Move: Watch Intel ahead of 'Unleashed' event 04/15/21 TSMC - TSM TSM TSMC $120.99 / -1.78 (-1.45%) 04/01/21 Unusually active option classes on open April 1st 03/25/21 Taiwan Semi call volume above normal and directionally bullish 03/04/21 Taiwan Semi call volume above normal and directionally bullish 02/26/21 Taiwan Semi call volume above normal and directionally bullish
Initiation	Property Solutions Acquisition initiated with a Buy at Benchmark » 06:22 04/13/21 04/13 06:22 04/13/21 06:22 PSAC Property Solutions Acquisition $13.00 / -1.985 (-13.25%) Benchmark initiated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Options PSAC Property Solutions Acquisition $13.00 / -1.985 (-13.25%) 01/28/21 FF to become public through $3.4B Property Solutions Acquisition combination PSAC Property Solutions Acquisition $13.00 / -1.985 (-13.25%) 04/09/21 Largest borrow rate increases among liquid names 03/11/21 Largest borrow rate increases among liquid names 02/25/21 Largest borrow rate increases among liquid names 02/23/21 Largest borrow rate increases among liquid names

Hot Stocks	Searchlight Capital to acquire Technical Airborne Components from TransDigm » 06:22 04/13/21 04/13 06:22 04/13/21 06:22 TDG TransDigm $623.43 / +8.19 (+1.33%) Technical Airborne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TDG TransDigm $623.43 / +8.19 (+1.33%) 03/01/21 TransDigm to divest ScioTeq and TREALITY businesses to OpenGate for $200M 02/16/21 Third Point buys Upstart, exits Caesars in Q4 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/09/21 TransDig is not providing FY21 guidance TDG TransDigm $623.43 / +8.19 (+1.33%) 03/31/21 Cowen TransDigm lagging performance presents attractive entry point, says Cowen 03/26/21 Goldman Sachs Hexcel downgraded to Sell from Neutral at Goldman Sachs 02/10/21 Credit Suisse TransDigm price target raised to $663 from $647 at Credit Suisse 02/10/21 Truist TransDigm price target raised to $562 from $500 at Truist TDG TransDigm $623.43 / +8.19 (+1.33%) 02/09/21 TransDigm reports Q1 adjusted EPS $1.97, consensus $1.99 11/12/20 TransDigm not providing FY21 guidance due to COVID-19 11/12/20 TransDigm reports Q4 adjusted EPS $2.89, consensus $1.98 11/11/20 Notable companies reporting before tomorrow's open 04/15/21 Aerospace & Defense
Earnings	Lucira Health sees Q1 revenue $4.0M-$4.5M, consensus $9.42M » 06:22 04/13/21 04/13 06:22 04/13/21 06:22 LHDX Lucira Health $10.83 / +2.27 (+26.52%) Guidance taken from the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly LHDX Lucira Health $10.83 / +2.27 (+26.52%) 04/12/21 FDA authorizes first single-use, PCR quality otc Lucira Covid test 04/09/21 Lucira Health COVID-19 test kit identifies viral variants 02/11/21 Lucira Health launches self-administered COVID-19 test in the U.S. 02/08/21 Lucira Health Inc trading resumes LHDX Lucira Health $10.83 / +2.27 (+26.52%) 06:04 Today BofA Lucira Health downgraded to Underperform from Buy at BofA 03/02/21 Lucira Health initiated with an Outperform at LifeSci Capital 03/02/21 William Blair Lucira Health initiated with an Outperform at William Blair 03/02/21 BofA Lucira Health initiated with a Neutral at BofA 05 Feb LHDX Lucira Health $10.83 / +2.27 (+26.52%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech
Downgrade	Nuance downgraded to Neutral from Outperform at Wedbush » 06:22 04/13/21 04/13 06:22 04/13/21 06:22 NUAN Nuance $52.80 / +7.21 (+15.81%) Wedbush analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Nuance trading resumes 04/12/21 Nuance to resume trading at 09:00ET 04/12/21 Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 04/12/21 Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Jefferies Microsoft deal emphasizes healthcare cloud focus, says Jefferies 04/12/21 Stifel Microsoft a 'logical buyer' of Nuance, says Stifel 04/12/21 B. Riley Nuance possible takeout positive for peer LivePerson, says B. Riley 04/12/21 Wedbush Nuance deal would be 'trophy' for Microsoft, says Wedbush NUAN Nuance $52.80 / +7.21 (+15.81%) 02/08/21 Nuance raises FY21 revenue view to $1.34B-$1.38B from $1.33B-$1.37B 02/08/21 Nuance sees Q2 EPS 14c-18c, consensus 18c 02/08/21 Nuance reports Q1 adjusted EPS 20c, consensus 18c 11/18/20 Nuance says FY21 guidance reflects continuing Enterprise revenue growth NUAN Nuance $52.80 / +7.21 (+15.81%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says NUAN Nuance $52.80 / +7.21 (+15.81%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector NUAN Nuance $52.80 / +7.21 (+15.81%) 04/07/21 Nuance call volume above normal and directionally bullish 03/23/21 Nuance call buyer realizes 9% same-day gains 02/08/21 Nuance options imply 10.5% move in share price post-earnings
Periodicals	Barclays to replace Synchrony as Gap's credit-card issuer, WSJ reports » 06:20 04/13/21 04/13 06:20 04/13/21 06:20 GPS Gap $32.77 / +0.34 (+1.05%) , SYF Synchrony $43.16 / +0.34 (+0.79%) , BCS Barclays $10.35 / +0.14 (+1.37%) Barclays (BCS) will take… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GPS SYF BCS GPS Gap $32.77 / +0.34 (+1.05%) 06:19 Today Synchrony says will not renew financing partnership with Gap 03/25/21 Gap agrees to sell Janie and Jack brand to Go Global Retail 03/25/21 Gap agrees to sell Janie and Jack brand to Go Global Retail 03/04/21 Gap recorded $56M impairment charge in Q4 related to Intermix SYF Synchrony $43.16 / +0.34 (+0.79%) 06:19 Today Synchrony says will not renew financing partnership with Gap 03/15/21 Synchrony reports February net charge offs 4.1% vs. 3.0% prior month 03/03/21 Synchrony, Ashley HomeStore renew consumer financing program agreement 02/16/21 Synchrony reports January net charge offs 3.0% vs. 3.1% prior month BCS Barclays $10.35 / +0.14 (+1.37%) 02/18/21 Barclays committed to medium-term targets, including RoTE of over 10% over time 02/18/21 Barclays sees 'meaningful' y/y RoTe improvement in 2021 02/18/21 Barclays declares 1.0p 2020 full year dividend 01/04/21 Penn National CFO David Williams steps down, Felicia Hendrix to succeed GPS SYF BCS GPS Gap $32.77 / +0.34 (+1.05%) 03/15/21 Wells Fargo Gap price target raised to $40 from $32 at Wells Fargo 03/09/21 MKM Partners Gap price target raised to $29 from $21 at MKM Partners 03/08/21 Barclays Gap price target raised to $32 from $27 at Barclays 03/08/21 Deutsche Bank Gap price target raised to $31 from $26 at Deutsche Bank SYF Synchrony $43.16 / +0.34 (+0.79%) 04/08/21 Evercore ISI Synchrony initiated with an Outperform at Evercore ISI 04/01/21 Morgan Stanley Synchrony price target raised to $54 from $53 at Morgan Stanley 03/26/21 Morgan Stanley Capital One, Synchrony have most upside from Fed change, says Morgan Stanley 03/18/21 Oppenheimer Alliance Data price target raised to $130 from $85 at Oppenheimer BCS Barclays $10.35 / +0.14 (+1.37%) 04/12/21 Deutsche Bank Barclays price target raised to 230 GBp from 200 GBp at Deutsche Bank 04/06/21 Morgan Stanley Barclays price target raised to 190 GBp from 160 GBp at Morgan Stanley 03/22/21 JPMorgan Barclays price target raised to 210 GBp from 190 GBp at JPMorgan 03/22/21 JPMorgan Barclays price target raised to 210 GBp from 190 GBp at JPMorgan GPS SYF BCS GPS Gap $32.77 / +0.34 (+1.05%) 03/04/21 Gap sees FY21 EPS $1.20-$1.35, consensus $1.28 03/04/21 Gap reports Q4 EPS 61c, consensus 18c 03/04/21 Notable companies reporting after market close 11/24/20 Gap reports Q3 Old Navy SSS up 17% y/y SYF Synchrony $43.16 / +0.34 (+0.79%) 01/29/21 Synchrony reports Q4 EPS $1.24, consensus 91c 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open 11/02/20 Fly Intel: What to watch in PayPal earnings report BCS Barclays $10.35 / +0.14 (+1.37%) 02/18/21 Barclays reports Q4 group profit before tax GBP0.6B vs. GBP1.1B last year 10/23/20 Barclays reports Q3 group profit before tax GBP 1.1B vs. GBP 0.2B last year 10/13/20 Fly Intel: What to watch in next round of big banks' earnings reports GPS BCS GPS Gap $32.77 / +0.34 (+1.05%) 03/08/21 Gap mulling options, including possible sale, for China business, Bloomberg says 03/08/21 Gap said to consider sale of China business, Bloomberg says 03/05/21 Gap CEO sees 'peacocking effect' as people emerge from Covid, WSJ reports 02/28/21 Macy's, Gap letting customers buy now, pay later, WSJ reports BCS Barclays $10.35 / +0.14 (+1.37%) 03/18/21 Goldman in talks to take over JetBlue credit-card program, WSJ reports 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says 02/18/21 Barclays CEO sees staff returning to office this year, Bloomberg reports 12/16/20 Barclays mulls raising bonus pool for traders by roughly 10%, Bloomberg says GPS SYF BCS GPS Gap $32.77 / +0.34 (+1.05%) 03/04/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday SYF Synchrony $43.16 / +0.34 (+0.79%) 01/29/21 Fly Intel: Pre-market Movers 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday BCS Barclays $10.35 / +0.14 (+1.37%) 03/12/21 Lennar downgrade, Barclays upgrade among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 04/27/21 Synchrony - SYF 04/30/21 Barclays - BCS 05/11/21 Gap Inc. 05/20/21 Synchrony Financial GPS BCS GPS Gap $32.77 / +0.34 (+1.05%) 04/12/21 Gap call buyer realizes 60% same-day gains 03/10/21 Gap call volume above normal and directionally bullish 03/05/21 Early notable gainers among liquid option names on March 5th 02/02/21 Gap call volume above normal and directionally bullish BCS Barclays $10.35 / +0.14 (+1.37%) 12/16/20 Barclays call volume above normal and directionally bullish 12/14/20 Unusual call flow in option market yesterday 12/11/20 Short-term premium buyer in Barclays 12/11/20 Unusually active option classes on open December 11th
Upgrade	Babcock upgraded to Overweight from Neutral at JPMorgan » 06:20 04/13/21 04/13 06:20 04/13/21 06:20 BCKIF Babcock $3.14 / + (+0.00%) JPMorgan analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BCKIF Babcock $3.14 / + (+0.00%) 01/27/21 Barclays Babcock downgraded to Underweight from Overweight at Barclays 01/08/21 JPMorgan Babcock price target lowered to 335 GBp from 400 GBp at JPMorgan 01/04/21 Exane BNP Paribas Babcock downgraded to Underperform from Neutral at Exane BNP Paribas 12/09/20 JPMorgan Babcock price target lowered to 400 GBp from 405 GBp at JPMorgan

Events

Earnings calls, analyst events, roadshows and more

IMCR
Today at 07:30

Immunocore - IMCR Conference Calls
BFRA
Today at 08:00

Biofrontera - BFRA Conference Calls
OGI
Today at 08:00

Organigram - OGI Conference Calls
EARS
Today at 08:00

Auris Medical - EARS Conference Calls
Today at 08:30

Consumer Price Index M/M: March 2021 Government Event
Today at 08:30

Consumer Price Index Y/Y: March 2021 Government Event
Today at 08:30

CPI Ex-Food & Energy M/M: March 2021 Government Event
Today at 08:30

CPI Ex Food & Energy Y/Y: March 2021 Government Event
KKR
Today at 08:30

KKR & Co. Inc. Firm Sponsored Meetings
Today at 08:55

Redbook Store Sales Y/Y: 4/10/21 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays $23.45-24.10 6.5M Shares GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank $35.10 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares
Fri	No deals

View All Syndicate Announcements »

Axonics launches ARTISTRY study for Axonics r-SNM System patients

TODAY'S FREE FLY STORIES

Get Full Fly Access